news
FDA approves Lutathera for somatostatin receptor-positive GEP-NETs
The FDA has approved Lutathera for the treatment of a type of cancer that affects the pancreas the gastrointestinal tract...
List view / Grid view
Anti-Cancer Therapeutics
news
Combination chemotherapy may significantly improve treatment for glioblastoma
Addition of hydroxyurea to current chemotherapy significantly improved survival in animal models of glioblastoma...
news
Cardiff Met develops new cancer treatment
Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a valuable treatment option for cancer...
news
Ogivri approved as the first biosimilar against certain breast and stomach cancers
The FDA has approved Ogivri as a biosimilar to Herceptin for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene...
news
Scientists identify bacterial link with oesophageal cancer
Researchers at NYU Langone Health's Perlmutter Cancer Center report that at least three kinds of bacteria in the mouths of Americans may directly affect their risk of developing oesophageal cancer.
news
Pembrolizumab shows hope for cancerous gestational trophoblastic disease
An immunotherapy drug can be used to cure a rare type of cancer arising from pregnancy when existing treatments have failed...
news
Cell-weighing method may predict how drugs will affect cancer cells
Cell-weighing technique may predict which therapies a patient is most sensitive or resistant to...
news
Fat cells may inactivate chemotherapeutic drug
A study has shown that Adipocytes can absorb and metabolise the chemotherapeutic agent daunorubicin, reducing its ability to kill cancer cells.
news
Proton therapy may be better option for patients with esophageal cancer
Proton beam therapy, in combination with chemotherapy, may be a better treatment option than traditional radiation therapy techniques...
news
NIH launches $215m partnership for cancer immunotherapy strategies
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
news
PI3K inhibitors show hope for rare bone cancers
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
news
Neratinib defeats the Ras genes notorious for causing cancer
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
news
TK216-vincristine combination for Ewing sarcoma identified
TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress...
news
Alcohol aversion drug disulfiram may combat chemotherapy resistance
Alcohol aversion drug disulfiram may combat chemotherapy resistance in non-small cell lung cancer...
news
Parkinson’s disease drug carbidopa shows anticancer effects
Research shows the Parkinson's disease drug carbidopa displays significant anticancer effects in human cell lines...
